Influenza, Human D007251

Diseases [C] » Infections [C01] » Respiratory Tract Infections » Influenza, Human

Diseases [C] » Respiratory Tract Diseases [C08] » Respiratory Tract Infections » Influenza, Human

Diseases [C] » Infections [C01] » Virus Diseases » RNA Virus Infections » Orthomyxoviridae Infections » Influenza, Human

Description

An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.   MeSH

Phase 1 Indicated Drugs (89)


Organization Involved with Phase 4 Indications (214)

Abbott

Adimmune Corporation

Agency for Science, Technology and Research

Alaska Native Tribal Health Consortium

Alaska State Public Health Laboratories

All India Institute of Medical Sciences

Altimmune, Inc.

Anhui Medical University

AstraZeneca

Azienda Ospedaliera Universitaria Senese

Baylor Scott and White

Baylor University

Bel-Rea Institute

Ben Gurion University

Bill and Melinda Gates Foundation

Boehringer Ingelheim

Brown University

Butantan Institute

Canadian Center for Vaccinology

Canadian Institutes of Health Research (CIHR)

Cancer Research Network

Capital Medical University

Case Western Reserve University

Centers for Disease Control and Prevention-Arctic Investigations Program

Centers for Disease Control and Prevention (CDC)

Centre pour le developpement des vaccines, Mali

Changchun Institute of Biological Products Co., Ltd.

Chengdu Institute of Biological Products Co.,Ltd.

China Academy of Chinese Medical Sciences

China National Biotec Group Co., Ltd

Chinese University of Hong Kong

CONSORTIUM MEDTEQ

Covance

Crucell

CSL Behring

Dalhousie University

D'Antonio Consultants International, Inc.

Dartmouth University

deCODE genetics

Department of Health and Human Services

Department of Veteran Affairs

Duke University

Emory University

Erasmus University Rotterdam

Eurogenerics NV

European Commission

Food and Drug Administration

Fourmed Gyogyhaz Kft.

Free University of Brussels

Fundação de Amparo à Pesquisa do Estado de São Paulo

German Federal Institute of Sport Science

Ghent University

GlaxoSmithKline

Government of China

Government of France

Government of Hong Kong

Government of Quebec

Government of Singapore

Government of Taiwan

Government of Thailand

Green Cross Corporation

Guangzhou Medical University

Harvard University

Healthcentric Advisors

Health Sciences North Research Institute

Hebrew University

Henry M. Jackson Foundation for the Advancement of Military Medicine

Hoosier Cancer Research Network

Hospital Del Nino, Panama

Hospital Jose Domingo de Obaldia, Panama

Hospital Nacional San Juan de Dios de San Miguel, El Salvador

Hospital Nacional San Juan de Dios de Santa Ana, El Salvador

Hualan Biological Engineering, Inc.

Hunan University of Traditional Chinese Medicine

Icahn School of Medicine at Mount Sinai

Imperial College London

Influenza Foundation of Thailand

Inova Health System

Insight Therapeutics, LLC

Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products

Institut National de la Santé Et de la Recherche Médicale, France

Institut national de sante publique du Quebec

Institut Pasteur

International Clinical Epidemiology Network (INCLEN) TRUST

Johns Hopkins University

Kaiser Permanente

Kameda Medical Center

Katholieke Universiteit Leuven

Kingston, Frontenac, Lanark Health Unit

Korea University

LG

London Road Diagnostic Clinic and Medical Centre

Lytics

Mahidol University

Marshfield Clinic Research Foundation

Materia Medica Holding

Max Planck Institute

Mayo Clinic

McGill University

McMaster University

MEDICAL INTERNATIONAL TECHNOLOGIES (MIT CANADA) INC.

Medical Research Council, The Gambia

MedImmune

Merck

Mount Sinai Hospital, Canada

Nanchang University

Nanyang Technological University

National Centre for Epidemiology, Hungary

Organization Involved with Phase 3 Indications (156)

Organization Involved with Phase 2 Indications (198)

Emergo Therapeutics, Inc.

Eurocine Vaccines AB

Far East Bio-Tec Co., Ltd

Fay West Family Practice, Scottdale, PA

Free University of Berlin

French National Agency for Research on AIDS and Viral Hepatitis

Fudan University

Gain Medical Research Centre

Genentech

Genome Protection, Inc

George Washington University

Georgia Clinical Research

Global Clinical Professionals, Miami, FL

Good Health Solutions

Government of Norway

Hammersmith Medicines Research

Harrison Clinical Research

Healthcare Discoveries Inc.

HealthCare Partners Medical Group LLC, Los Angeles

Health Concepts, Rapid City, SD 57702

Hemispherx Biopharma

Hermitage Medicentres

Highland Clinical Research, Salt Lake City, UT

Hillcrest Family Practice

Holy Name Medical Center, Teaneck, NJ

Holy Trinity Medical Clinic, Harbor City, CA

Hometown Urgent Care & Occupational Health, Dayton

Hospital Infantil Dr. Robert Reid Cabral

Hualan Biological Bacterin Co. Ltd.

hVIVO Services Limited

Immune Targeting Systems Ltd

INC Research

Indiana University

Instituto Mexicano del Seguro Social

Integrated Clincal Trial Services Inc.

Integrated Medical Research, PC

Intercell

Internistische Gemeinschaftspraxis, Dr. Regner & Dr. Schmitt, Mainz

inVentiv

IRC Clinics, Towson

Isala Clinics, Zwolle, The Netherlands

Jacksonville Center for Clinical Research

Janssen Pharmaceutica NV

Jean Brown Research

J. Lewis Research, Inc

Johnson County Clin-Trials

Kazakh National Medical University

Kentucky Pediatric and Adult Research

Kitasato University

Lakeview Medical Research, Summerfield, FL 34491

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.